Study provides rigorous data to support clinical evaluation of THC as a low-toxic therapy option in acute leukemia patients. In related work, full-spectrum, natural derivatives of cannabis may work more effectively than their pharmaceutical counterparts.
View this review (yellow link) or download:
Dronabinol Has Preferential Antileukemic Activity in Acute Lymphoblastic and Myeloid Leukemia With Lymphoid Differentiation Patterns Download
This paper is also stored here: http://bit.ly/2KVVXnD inside the CED Foundation Archive
To explore related information, click the keywords below: